Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fetal heart monitor approval

This article was originally published in The Gray Sheet

Executive Summary

Swedish firm Neoventa is looking for a U.S.-based partner to help market the STAN S31 fetal heart monitor, after announcing PMA approval Nov. 2. FDA's Obstetrics and Gynecology Devices Advisory Panel unanimously recommended approval of the device, with conditions, at a June 23 meeting (1"The Gray Sheet" June 27, 2005, p. 15). Besides modifying the device for easier use by American clinicians, FDA is also requiring Neoventa to distribute educational materials with the device...
Advertisement

Related Content

Panel Endorses STAN Fetal Monitor, Emphasizes Need For Clinician Education
Panel Endorses STAN Fetal Monitor, Emphasizes Need For Clinician Education
Advertisement
UsernamePublicRestriction

Register

MT022864

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel